REMAP-CAP’S NEW TRIAL DEVELOPMENTS
Audrey Shearer Audrey Shearer

REMAP-CAP’S NEW TRIAL DEVELOPMENTS

The world of REMAP-CAP is constantly evolving, here’s what’s new!

REMAP-CAP, a groundbreaking trial that has most recently been primarily focused on finding treatments for COVID-19, has now been selected by the National Institute for Healthcare and Research to evaluate therapeutic interventions for influenza.

Read More
ACTA Insights with Audrey
Audrey Shearer Audrey Shearer

ACTA Insights with Audrey

After two years of online meetings, attending the Australian Clinical Trials Alliance Annual Science meeting in Adelaide in November felt fantastic. It was a whirlwind of activity, new technology, connections, learning, and, importantly, an excellent opportunity to connect with industry peers.

Read More